http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113274544-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae3a956054a5b4dd96686a962474809 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0061 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00 |
| filingDate | 2021-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33c19e105d70f36722ef737ead0aa0f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd63536c8b7c28d6f4830b786b29b516 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fead0b80739ae6eb70f527abff7fc19 |
| publicationDate | 2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113274544-A |
| titleOfInvention | PEG hemostatic powder |
| abstract | The invention provides a PEG hemostatic powder system based on controllable cross-linking and degradation, and a preparation method and application thereof. The hemostatic powder is composed of the PEG-1 and PEG-2, and the PEG-1 and PEG-2 can react with each other to form a gel in the presence of blood, thereby enhancing the strength of the hemostatic powder and the ability to interact with tissues. PEG hemostatic powder can absorb a large amount of water, and the degradation time can be adjusted to suit different bleeding locations and degrees of bleeding. |
| priorityDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.